Treatment dynamics of bone‐targeting agents among men with bone metastases from prostate cancer in the United States
Sign Up to like & getrecommendations! Published in 2018 at "Pharmacoepidemiology and Drug Safety"
DOI: 10.1002/pds.4360
Abstract: To examine the dynamics of treatment with 2 bone‐targeting agents (BTAs)—denosumab and zoledronic acid—among men with bone metastases from prostate cancer. read more here.
Keywords: bone targeting; bone metastases; metastases prostate; targeting agents ... See more keywords